A Whey Protein-based Nutritional Supplement Enriched in Vitamin D, Leucine and Calcium for Patients With Parkinsonism Undergoing Rehabilitation Treatment: a Randomized Trial
| Registry | NCT03124277 |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: single, treatment |
| Enrollment | 150 (Actual) |
| Sponsor | Emanuele Cereda (Other); collaborators: ASST Gaetano Pini-CTO, U.S. Riabilitazione Parkinson, Fondazione Gaetano e Piera Borghi di Brebbia, Ospedale Generale Di Zona Moriggia-Pelascini |
| Conditions | Disability Physical |
| Interventions | Fortifit®, Control Group (Dietary supplement, other) |
| Dates | start 2017-04-26, primary completion 2018-01-17, completion 2018-01-17, first posted 2017-04-21, last updated 2025-05-01 |
| Locations | 1 site in Italy |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Disability Physical All trials of Fortifit® All trials of Control Group
This randomized, trial will tested the hypothesis that nutritional supplementation with whey protein, essential amino acids - mainly leucine - vitamin D and calcium would increase the efficacy of physical rehabilitation in old adults suffering from Parkinson's disease o parkinsonism
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Fortifit® | Experimental | Dietary Supplement: Fortifit® | Best local diet + two servings (40 grams each) of powder (Fortifit®; Nutricia) which has to be dissolved in 125 ml of water. Per serving, 20 g whey protein, 3 g total leucine, 9 g carbohydrates, 3 g fat, 800 IU vitamin D, and a mixture of vitamins, minerals, and fibers. |
| Control group | Other | Other: Control Group | Best local diet |
Sex: All
Inclusion Criteria: * Parkinson's disease o parkinsonism * admission for physical rehabilitation * Informed consent Exclusion Criteria: * Any malignant disease during the last five years * Known kidney failure (previous glomerular filtration rate <30 ml/min); * Known liver failure (Child B or C) * Psychiatric disease * Endocrine disorders associated with disorders of calcium metabolism (excluding osteoporosis) * Indications related to the study product: More than 10 μg (400 IU) of daily Vitamin D intake from medical sources More than 500 mg of daily calcium intake from medical sources. Adherence to a high energy or high protein diet up or use of protein containing or amino acid containing nutritional supplements up to three months before starting the study. * Known allergy to milk, milk products or other components of the proposed interventions * Indication to or ongoing artificial nutrition support * Inclusion in other nutrition intervention trials * Investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements * Refusal
| Facility | City | Country | Status |
|---|---|---|---|
| Centro Parkinson, ASST Gaetano Pini-CTO | Milan | Italy |